[1]
|
M. H. Criqui, J. O. Denenberg, R. D. Langer, et al., “The Epidemiology of Peripheral Arterial Disease: Importance of Identifying the Populationat Risk,” Vascular Medicine, Vol. 2, No. 3, 1997, pp. 221-226.
|
[2]
|
J. M. Murabito, R. B. D’Agostino, H. Silbershatz, et al., “Intermittent Claudication. A Risk Profile from the Framingham Heart Study,” Circulation, 1997, Vol. 96, pp. 44-49.
|
[3]
|
R. A. Linsky, K. S. Korr and I. Sadiq, “Contemporary Management of Peripheral Arterial Disease: A Review,” Medicine and Health Rhode Island, Vol. 91, No. 10, 2008, pp. 305-308.
|
[4]
|
A. T. Hirsch, Z. J. Haskal, et al., “ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (Lower Extremity, Renal Mesenteric, and Abdominal Aortic): Executive Summary: A Collaborative Report from the American Association for Vascular Surgery/Society for Vascular Surgery,” Journal of the American College of Cardiology, Vol. 47, No. 6, 2006, pp. 1239-1312.
|
[5]
|
M. D. McDaniel and J. L. Cronenwett, “Basic Data Related to the Natural History of Intermittent Claudication,” Annals of Vascular Surgery, Vol. 3, No. 3, 1989, pp. 273-277. doi:10.1016/S0890-5096(07)60040-5
|
[6]
|
A. M. Imparato, G. E. Kim, T. Davidson and J. G. Crowley, “Intermittent Claudication: Its Natural Course,” Surgery, Vol. 78, No. 6, 1975, pp. 795-799.
|
[7]
|
N. N. Dagher and J. G. Modrall, “Pharmacotherapy before and after Revascularization: Anticoagulation, Antiplatelet Agents, and Statins,” Seminars in Vascular Surgery, Vol. 20, No. 1, 2007, pp. 10-14.
|
[8]
|
B. Yoffe, et al., “Experimental Study of a Novel Suture-Less Aortic Anastomotic Device,” European Journal of Vascular and Endovascular Surgery, Vol. 34, No. 1, 2007, pp. 79-86. doi:10.1016/j.ejvs.2007.02.004
|